We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nanotherapeutic Drug Mimics Platelet Behavior to Dissolve Blood Clots

By LabMedica International staff writers
Posted on 19 Jul 2012
Print article
A nanoparticle-based therapeutic strategy that mimics the behavior of blood platelets breaks up blood clots with minimal levels of clot-dissolving drugs.

Investigators at Harvard University’s Wyss Institute (Cambridge, MA, USA) devised a novel microscale aggregate comprised of nanoparticles coated with the clot-dissolving drug tissue plasminogen activator. The aggregates were designed to be injected into the blood stream where they would break up into discrete nanoparticles when exposed to areas of abnormally high fluid shear stress. Such areas could be caused by narrowing of blood vessels by atherosclerotic plaques.

Results published in the July 5, 2012, online edition of the journal Science revealed that when the coated aggregates were administered intravenously to mice, these shear-activated nanotherapeutics induced rapid clot dissolution in a mesenteric injury model, restored normal flow dynamics, and increased survival in an otherwise fatal mouse pulmonary embolism model.

By targeting and concentrating the drug at the precise site of the blood vessel obstruction, the investigators were able to achieve improved survival in mice with occluded lung vessels with less than 1/50th of the normal therapeutic dose.

Senior author Dr. Donald E. Ingber, professor of bioengineering at Harvard University, said, “The vascular nanotherapeutic we developed that selectively becomes activated in regions of high shear stress, much like living platelets do, is a wonderful example of how we at the Wyss Institute take inspiration from biology, and how biomimetic strategies can lead to new and unexpected solutions to age-old problems that existing technologies cannot address.”

Related Links:
Harvard University’s Wyss Institute



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.